ROSA MARIA HERNANDEZ MARTIN-rekin lankidetzan egindako argitalpenak (11)

2023

  1. Computational and Experimental Evaluation of the Immune Response of Neoantigens for Personalized Vaccine Design

    International Journal of Molecular Sciences, Vol. 24, Núm. 10

2020

  1. Overcoming the inflammatory stage of non-healing wounds: In vitro mechanism of action of negatively charged microspheres (NCMS)

    Nanomaterials, Vol. 10, Núm. 6, pp. 1-14

2019

  1. Nanomedikamentuak bularreko minbiziaren tratamendu gisa

    Elhuyar: zientzia eta teknika, Núm. 336, pp. 68-71

2018

  1. Kosmetika onkologikoa: kimioterapiak eta erradioterapiak larruazalean eragindako efektu desiragaitzak eta horiek tratatzeko konposatu naturaletan oinarritutako formulazio berriak

    Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 33, pp. 35-53

2015

  1. Design and evaluation of surface and adjuvant modified PLGA microspheres for uptake by dendritic cells to improve vaccine responses

    International Journal of Pharmaceutics, Vol. 496, Núm. 2, pp. 371-381

2014

  1. Designing improved poly lactic-co-glycolic acid microspheres for a malarial vaccine: Incorporation of alginate and polyinosinic-polycytidilic acid

    Journal of Microencapsulation, Vol. 31, Núm. 6, pp. 560-566

2013

  1. Malaria vaccine adjuvants: Latest update and challenges in preclinical and clinical research

    BioMed Research International, Vol. 2013

2012

  1. Combination of immune stimulating adjuvants with poly(lactide-co-glycolide) microspheres enhances the immune response of vaccines

    Vaccine, Vol. 30, Núm. 3, pp. 589-596

  2. Plasmodium falciparum malaria vaccines: Current status, pitfalls and future directions

    Expert Review of Vaccines, Vol. 11, Núm. 9, pp. 1071-1086

2011

  1. An Overview on the Field of Micro- and Nanotechnologies for Synthetic Peptide-Based Vaccines

    JOURNAL OF DRUG DELIVERY, Vol. 2011

  2. Encapsulation of Aβ 1-15 in PLGA microparticles enhances serum antibody response in mice immunized by subcutaneous and intranasal routes

    European Journal of Pharmaceutical Sciences, Vol. 44, Núm. 3, pp. 200-206